Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples
Oslo University Hospital
50 participants
Apr 28, 2020
INTERVENTIONAL
Conditions
Summary
Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients will be randomized (1:1) to either follow standard of care (SOC) or having every second poli clinical visit without entering the hospital HBM; Home Based Monitoring). They are to take a capillary finger-prick blood sample themselves, send it to the laboratory for analysis and then they will get a telecom follow-up that day from their transplant physician. Outcome is no difference with regards to being able to follow the randomized follow-up procedure.
Eligibility
Inclusion Criteria6
- Kidney only transplant
- Immunosuppressive therapy With at least one of; tacrolimus, cyclosporine, everolimus, sirolimus, mycophenolate
- Standard immunological risk; no DSA, no PRA, not ABO-incompatible transplant
- Age above 18 years
- Followed at Oslo University Hospital-Rikshospitalet transplant center
- Written informed consent
Exclusion Criteria2
- Pregnant or breast feeding female recipients
- Ongoing acute rejection episodes at time of inclusion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard post-transplant follow-up
Patients take capillary blood sample by finger-prick and send to lab for analyses. Telecom follow-up that day by treating physician
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04369612